Research map: CAR design equips diverse immune cells with unique antigen-specific activation identities

Back to the article

Papers in this map

  1. Simultaneous epitope and transcriptome measurement in single cells · Marlon Stoeckius · 2017 · 3446 citations · Cited by this paper
  2. Stem cells-derived natural killer cells for cancer immunotherapy: current protocols, feasibility, and benefits of ex vivo generated natural killer cells in treatment of advanced solid tumors · Hamid Khodayari · 2021 · 11 citations · Related
  3. CAR-T cell therapy: current limitations and potential strategies · Robert C. Sterner · 2021 · 2926 citations · Cited by this paper
  4. Rethinking lymphodepleting preconditioning in adoptive T cell therapy for durable tumor control · 2026 · Related
  5. NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 Activation · Cun-Yu Wang · 1998 · 2726 citations · Cited by this paper
  6. Depletion of IL-10 in CAR-NK cells augments reprogramming of the tumor microenvironment and ameliorates therapeutic efficacy · 2026 · Related
  7. Human chimeric antigen receptor macrophages for cancer immunotherapy · Michael Klichinsky · 2020 · 1499 citations · Cited by this paper
  8. AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer · 2026 · Related
  9. CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability · Xingzhe Ma · 2021 · 1025 citations · Cited by this paper
  10. CART-immune-related adverse events after BCMA CAR-T therapy · 2026 · Related
  11. Humanized mice for immune system investigation: progress, promise and challenges · Leonard D. Shultz · 2012 · 993 citations · Cited by this paper
  12. Unmasking Wnt-driven HCC: Inhibiting SMYD2 to overcome immune resistance · 2026 · Related
  13. CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy · Kevin Pan · 2022 · 667 citations · Cited by this paper
  14. Intraperitoneal delivery of the oncolytic virus CF17 improves tumor immunogenicity and survival in gastric cancer peritoneal metastasis · 2026 · Related
  15. The AP-1 transcription factor Batf controls TH17 differentiation · Barbara U. Schraml · 2009 · 657 citations · Cited by this paper
  16. Synergistic Cell-Cycle Repression by HDAC/EZH2 Co-Targeting in H3K27-Altered Diffuse Midline Glioma · 2026 · Related
  17. Transcriptional regulation of bcl-2 by nuclear factor κB and its significance in prostate cancer · Sergio Catz · 2001 · 536 citations · Cited by this paper
  18. Natural killer cell-derived extracellular vesicles reprogram cellular human immunity to enhance tumor cytotoxicity · 2026 · Related
  19. BCL-2 protein family: attractive targets for cancer therapy · Deeksha Kaloni · 2022 · 517 citations · Cited by this paper
  20. Chimeric antigen receptor modified hematopoietic stem cells (CAR-HSCs) arm all immune forces for anti-tumor in mice · 2025 · Related
  21. Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis · Raelene J. Grumont · 1999 · 403 citations · Cited by this paper
  22. MAPK-regulated transcription: a continuously variable gene switch? · Catherine A. Hazzalin · 2002 · 400 citations · Cited by this paper
  23. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells · Wataru Ise · 2011 · 387 citations · Cited by this paper
  24. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants · Daniel Hirschhorn · 2023 · 312 citations · Cited by this paper
  25. Zero-preserving imputation of single-cell RNA-seq data · George C. Linderman · 2022 · 300 citations · Cited by this paper
  26. A second-generation M1-polarized CAR macrophage with antitumor efficacy · Anhua Lei · 2023 · 294 citations · Cited by this paper
  27. Rewiring T-cell responses to soluble factors with chimeric antigen receptors · ZeNan Chang · 2018 · 267 citations · Cited by this paper
  28. Strategies to Address Chimeric Antigen Receptor Tonic Signaling · Adam Ajina · 2018 · 247 citations · Cited by this paper
  29. Cellular networks controlling T cell persistence in adoptive cell therapy · Jack D. Chan · 2021 · 247 citations · Cited by this paper
  30. Matrix metalloproteinase-8: Cleavage can be decisive · P VANLINT · 2006 · 245 citations · Cited by this paper
  31. Haematopoietic stem cell self-renewal in vivo and ex vivo · Adam C. Wilkinson · 2020 · 228 citations · Cited by this paper
  32. The analysis of the functions of human B and T cells in humanized NOD/shi-scid/γcnull (NOG) mice (hu-HSC NOG mice) · Y. Watanabe · 2009 · 225 citations · Cited by this paper
  33. Specificity of signaling by STAT1 depends on SH2 and C‐terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression · Pavel Kovarik · 2001 · 201 citations · Cited by this paper
  34. c-Myb Is Critical for B Cell Development and Maintenance of Follicular B Cells · Matthew Thomas · 2005 · 187 citations · Cited by this paper
  35. Role of PI3K/Akt signaling in memory CD8 T cell differentiation · Eui Ho Kim · 2013 · 186 citations · Cited by this paper
  36. Chimeric antigen receptor signaling: Functional consequences and design implications · Silke E. Lindner · 2020 · 185 citations · Cited by this paper
  37. Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities · Ilias Christodoulou · 2021 · 171 citations · Cited by this paper
  38. Chemically defined cytokine-free expansion of human haematopoietic stem cells · Masatoshi Sakurai · 2023 · 161 citations · Cited by this paper
  39. 4-1BB enhancement of CAR T function requires NF-κB and TRAFs · Gongbo Li · 2018 · 154 citations · Cited by this paper

Source: OpenAlex (CC0)